| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.32 | 7e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.28 | 8e-07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.25 | 3e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.2 | 0.006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.04 |